Try Ask OE! Our NEW Advanced AI Enabled Search
Dive into the Largest Database of
Musculoskeletal Evidence
Make a selection below to explore our full database of 21 results matching: "Alendronate"
ACE Reports
(21 Reports)
ACE Reports
Originals
(0 Articles)
Originals
Podcasts
(0 Videos)
Podcasts
Our Al driven High Impact metric predicts an article's future number of citations by considering the content of the article.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Open Advanced Search
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Metabolic Disorders
Romosozumab versus placebo, alendronate, and teriparatide for postmenopausal osteoporosis
Climacteric. 2018 Apr;21(2):189-195
Romosozumab versus placebo, alendronate, and teriparatide for postmenopausal osteoporosis
Climacteric. 2018 Apr;21(2):189-195
Metabolic Disorders
Zoledronic Acid, alendronate, and risedronate reduce vertebral, nonvertebral, and hip fracture
Osteoporos Int. 2016 Nov;27(11):3289-3300
Zoledronic Acid, alendronate, and risedronate reduce vertebral, nonvertebral, and hip fracture
Osteoporos Int. 2016 Nov;27(11):3289-3300
General Orthopaedics
Alendronate treatment for fibrous dysplasia, a rare skeletal disorder
J Clin Endocrinol Metab. 2014 Nov;99(11):4133-40.
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Alendronate treatment for fibrous dysplasia, a rare skeletal disorder
J Clin Endocrinol Metab. 2014 Nov;99(11):4133-40.
Metabolic Disorders
Comparison of risedronate, alendronate, zoledronate, and ibandronate in those with low BMD
Bone. 2016 Aug;89:52-8
Comparison of risedronate, alendronate, zoledronate, and ibandronate in those with low BMD
Bone. 2016 Aug;89:52-8
Arthroplasty
Effect of teriparatide versus alendronate or no medication on periprosethtic BMD in THA
J Arthroplasty. 2016 Jan;31(1):333-8
Effect of teriparatide versus alendronate or no medication on periprosethtic BMD in THA
J Arthroplasty. 2016 Jan;31(1):333-8
Metabolic Disorders
Combined parathyroid hormone+alendronate therapy versus PTH monotherpy for osteoporosis
J Invest Surg. 2015 Dec;28(6):309-16
Combined parathyroid hormone+alendronate therapy versus PTH monotherpy for osteoporosis
J Invest Surg. 2015 Dec;28(6):309-16
Arthroplasty
The effect of alendronate post-TKA on bone mineral density and clinical outcome
Bone Joint J. 2015 Mar;97-B(3):337-45
The effect of alendronate post-TKA on bone mineral density and clinical outcome
Bone Joint J. 2015 Mar;97-B(3):337-45
Metabolic Disorders
Discontinuing alendronate after 5 years of treatment, does it affect fracture risk?
JAMA. 2006 Dec 27;296(24):2927-38.
Discontinuing alendronate after 5 years of treatment, does it affect fracture risk?
JAMA. 2006 Dec 27;296(24):2927-38.
Metabolic Disorders
Combined & extended alendronate with teriparatide improves BMD in women with osteoporosis
J Bone Miner Res. 2014 Aug;29(8):1777-85
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Combined & extended alendronate with teriparatide improves BMD in women with osteoporosis
J Bone Miner Res. 2014 Aug;29(8):1777-85
Arthroplasty
Alendronate improves bone mineral density after total knee arthroplasty
J Bone Joint Surg Am. 2003 Nov;85-A(11):2121-6
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Alendronate improves bone mineral density after total knee arthroplasty
J Bone Joint Surg Am. 2003 Nov;85-A(11):2121-6
Hand & Wrist
Oral alendronate cannot yet be recommended for children with OI
J Clin Endocrinol Metab. 2011 Feb;96(2):355-64
Oral alendronate cannot yet be recommended for children with OI
J Clin Endocrinol Metab. 2011 Feb;96(2):355-64
Metabolic Disorders
Denosumab is superior to alendronate for improving cortical bone porosity post-menopause
Bone. 2014 Feb;59:173-9. doi: 10.1016/j.bone.2013.11.016. Epub 2013 Nov 22.
Denosumab is superior to alendronate for improving cortical bone porosity post-menopause
Bone. 2014 Feb;59:173-9. doi: 10.1016/j.bone.2013.11.016. Epub 2013 Nov 22.
Metabolic Disorders
WCO-IOF: Changes with QCT, DXA, and TBS between denosumab, alendronate, & placebo
WCO-IOF: Changes with QCT, DXA, and TBS between denosumab, alendronate, & placebo
Metabolic Disorders
Alendronate & zoledronate both reduce hip and vertebral fracture risk compared to placebo
Gynecol Endocrinol. 2013 Dec;29(12):1005-14. doi: 10.3109/09513590.2013.813468. Epub 2013 Sep 25
Alendronate & zoledronate both reduce hip and vertebral fracture risk compared to placebo
Gynecol Endocrinol. 2013 Dec;29(12):1005-14. doi: 10.3109/09513590.2013.813468. Epub 2013 Sep 25
General Orthopaedics
Alendronate is an effective way of increasing BMD and reducing bone turnover
J Int Med Res. 2011;39(1):302-10
Alendronate is an effective way of increasing BMD and reducing bone turnover
J Int Med Res. 2011;39(1):302-10
Metabolic Disorders
The role of alendronate in osteoporosis patients undergoing PLIF
J Neurosurg Spine. 2011 Apr;14(4):500-7. doi: 10.3171/2010.11.SPINE10245. Epub 2011 Jan 28
The role of alendronate in osteoporosis patients undergoing PLIF
J Neurosurg Spine. 2011 Apr;14(4):500-7. doi: 10.3171/2010.11.SPINE10245. Epub 2011 Jan 28
General Orthopaedics
Etidronate, alendronate, and reisendronate significantly reduce the risk of hip fracture
Curr Med Res Opin. 2011 Jun;27(6):1141-8. doi: 10.1185/03007995.2011.570747. Epub 2011 Apr 1
Etidronate, alendronate, and reisendronate significantly reduce the risk of hip fracture
Curr Med Res Opin. 2011 Jun;27(6):1141-8. doi: 10.1185/03007995.2011.570747. Epub 2011 Apr 1
General Orthopaedics
Alendronate is superior to alfacalcidol in preventing glucocorticoid-induced bone loss
N Engl J Med. 2006 Aug 17;355(7):675-84
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Alendronate is superior to alfacalcidol in preventing glucocorticoid-induced bone loss
N Engl J Med. 2006 Aug 17;355(7):675-84
Arthroplasty
Improved bone mineral density up to 12 months with a 6-month oral alendronate intervention
J Bone Joint Surg Am. 2006 Feb;88(2):267-72
Improved bone mineral density up to 12 months with a 6-month oral alendronate intervention
J Bone Joint Surg Am. 2006 Feb;88(2):267-72
Arthroplasty
Effectiveness of Alendronate versus Alfacalcidol in maintaining bone mineral density
Journal of Bone and Joint Surgery American; 2011; 93(A); 1203-1209
Effectiveness of Alendronate versus Alfacalcidol in maintaining bone mineral density
Journal of Bone and Joint Surgery American; 2011; 93(A); 1203-1209
Showing 1-20 of 21 results
1
2